Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Aug
20
Today In Oncology
Chemotherapy, Immunotherapy, and Targeted Therapy in Advanced, Refractory Malignancies
Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL
Study Supports Personalized Weight-Loss Intervention for Breast Cancer Survivors
Digital Integrative Medicine Program Improves Overall Survival in Patients Undergoing Systemic Cancer Treatment
County-Level Medical Debt Linked to Advanced-Stage Cancers, Worse Survival Among Newly Diagnosed U.S. Adults
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo